Cargando…
MEX3A knockdown inhibits the development of pancreatic ductal adenocarcinoma
BACKGROUND: Pancreatic ductal adenocarcinoma (PDA) is one of the most serious causes of death in the world due to its high mortality and inefficacy treatments. MEX3A was first identified in nematodes and was associated with tumor formation and may promote cell proliferation and tumor metastasis. So...
Autores principales: | Wang, Xing, Shan, Yu-Qiang, Tan, Qing-Quan, Tan, Chun-Lu, Zhang, Hao, Liu, Jin-Heng, Ke, Neng-Wen, Chen, Yong-Hua, Liu, Xu-Bao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048143/ https://www.ncbi.nlm.nih.gov/pubmed/32140076 http://dx.doi.org/10.1186/s12935-020-1146-x |
Ejemplares similares
-
SLPI knockdown induced pancreatic ductal adenocarcinoma cells proliferation and invasion
por: Zhang, Wei, et al.
Publicado: (2015) -
The effects of MEX3A knockdown on proliferation, apoptosis and migration of osteosarcoma cells
por: Wang, Bangmin, et al.
Publicado: (2021) -
Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma
por: Zhang, Yalu, et al.
Publicado: (2021) -
Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2021) -
Analysis of dynamic molecular networks for pancreatic ductal adenocarcinoma progression
por: Pan, Zongfu, et al.
Publicado: (2018)